Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Stern

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|April 4, 2006
Bead-isolated human CD4+CD25+ T regulatory cells are anergic and significantly suppress proliferation of CD4+CD25- T responder cellsEyad Elkord, Lucy Hopcraft, Debbie Burt, et al.
Experimental Cell Research|April 18, 2006
Cell surface 5T4 antigen is transiently upregulated during early human embryonic stem cell differentiation: effect of 5T4 phenotype on neural lineage formationChristopher M Ward, Angela M Eastham, Peter L Stern
Cancer Immunology, Immunotherapy : CII|June 8, 2006
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigenSumia Ali, Kate Mulryan, Taher Taher, et al.
Experimental Cell Research|January 20, 2004
Significant variations in differentiation properties between independent mouse ES cell lines cultured under defined conditionsChristopher M Ward, Katie M Barrow, Peter L Stern
Expert Review of Anticancer Therapy|December 4, 2009
5T4 as a target for immunotherapy in renal cell carcinomaEyad Elkord, Alaaeldin Shablak, Peter L Stern, et al.
Seminars in Cancer Biology|July 29, 2014
Understanding and exploiting 5T4 oncofoetal glycoprotein expressionPeter L Stern, Julie Brazzatti, Saladin Sawan, et al.
Journal of Cell Science|September 8, 2012
CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoproteinOwen J McGinn, Georgi Marinov, Saladin Sawan, et al.
British Medical Bulletin|August 15, 2002
Cancer vaccines and immunotherapySaid Dermime, Anne Armstrong, Robert E Hawkins, et al.
Journal of Cell Science|October 25, 2003
The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotencyChristopher M Ward, Katie Barrow, Andrew M Woods, et al.
Frontiers in Cellular Neuroscience|August 17, 2019
Expression of Oncofetal Antigen 5T4 in Murine Taste PapillaeYuka Takahashi, Hiroo Takahashi, Peter L Stern, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|April 4, 2006
Bead-isolated human CD4+CD25+ T regulatory cells are anergic and significantly suppress proliferation of CD4+CD25- T responder cellsEyad Elkord, Lucy Hopcraft, Debbie Burt, et al.
Experimental Cell Research|April 18, 2006
Cell surface 5T4 antigen is transiently upregulated during early human embryonic stem cell differentiation: effect of 5T4 phenotype on neural lineage formationChristopher M Ward, Angela M Eastham, Peter L Stern
Cancer Immunology, Immunotherapy : CII|June 8, 2006
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigenSumia Ali, Kate Mulryan, Taher Taher, et al.
Experimental Cell Research|January 20, 2004
Significant variations in differentiation properties between independent mouse ES cell lines cultured under defined conditionsChristopher M Ward, Katie M Barrow, Peter L Stern
Expert Review of Anticancer Therapy|December 4, 2009
5T4 as a target for immunotherapy in renal cell carcinomaEyad Elkord, Alaaeldin Shablak, Peter L Stern, et al.
Seminars in Cancer Biology|July 29, 2014
Understanding and exploiting 5T4 oncofoetal glycoprotein expressionPeter L Stern, Julie Brazzatti, Saladin Sawan, et al.
Journal of Cell Science|September 8, 2012
CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoproteinOwen J McGinn, Georgi Marinov, Saladin Sawan, et al.
British Medical Bulletin|August 15, 2002
Cancer vaccines and immunotherapySaid Dermime, Anne Armstrong, Robert E Hawkins, et al.
Journal of Cell Science|October 25, 2003
The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotencyChristopher M Ward, Katie Barrow, Andrew M Woods, et al.
Frontiers in Cellular Neuroscience|August 17, 2019
Expression of Oncofetal Antigen 5T4 in Murine Taste PapillaeYuka Takahashi, Hiroo Takahashi, Peter L Stern, et al.
Pageof 9